as on January 21, 2026 at 2:29 am IST
Day's High
3.50%
Upside
52 Week's Low
52 Week's High
30.08%
Downside
87.41%
Upside
Check Heron Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$273.2M
EPS (TTM)
-0.05
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
-0.18
EBITDA
4.0M
Revenue (TTM)
155.1M
Profit Margin
-8.76%
Return On Equity TTM
-2408.88%
Compare market cap, revenue, PE, and other key metrics of Heron Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $273.2M | -91.94% | NA | -8.76% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
The Heron Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Heron Therapeutics, Inc. investment value today
Current value as on today
₹94,062
Returns
Returns from Heron Therapeutics, Inc. Stock
Dollar Returns*
₹6,332 (+6.33%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Heron Therapeutics, Inc.. Average target price of $4.5
Get share price movements and forecasts by analysts on Heron Therapeutics, Inc..
What analysts predicted
68.22%UPSIDE
Target Price
$4.5
Current Price
$1.43
Analyzed by
10 Analysts
Target
$4.50
Heron Therapeutics, Inc. target price $4.5, a slight upside of 68.22% compared to current price of $1.43. According to 10 analysts rating.
Search interest for Heron Therapeutics, Inc. Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:54% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 37.2M → 38.21M (in $), with an average increase of 2.7% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 52.8% return, outperforming this stock by 65.7%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 77.4%
Profit Down
![]()
Netprofit is down for the last 4 quarters, 3.66M → -17.49M (in $), with an average decrease of 284.4% per quarter
Price Dip
![]()
In the last 7 days, HRTX stock has moved down by -4.7%
| Organisation | Heron Therapeutics, Inc. |
| Headquarters | 100 Regency Forest Drive, Cary, NC, United States, 27518 |
| Industry | Health Technology |
| CEO | Mr. Craig Alexander Collard |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Melissa Jarel | Executive Director of Legal |
Dr. John C. Arthur Ph.D. | Senior Vice President of Manufacturing & Supply |
Mr. Robert Sullivan | Senior Vice President of Oncology Care Franchise & Commercial Operations |
Mr. Craig Alexander Collard | CEO & Director |
Ms. Ira Duarte | Executive VP & CFO |
Dr. William P. Forbes Pharm. D., Pharm.D. | Executive VP & Chief Development Officer |
Mr. Mark E. Hensley | Executive VP & COO |
Mr. Ryan Craig | Vice President of Marketing |
Mr. John Aiken | Executive Director of People Management & Training |
Mr. Brett Fleshman | Chief Business Officer |
Heron Therapeutics, Inc. share price today is $1.43 as on at the close of the market. Heron Therapeutics, Inc. share today touched a day high of $1.48 and a low of $1.43.
Heron Therapeutics, Inc. share touched a 52 week high of $2.68 on and a 52 week low of $1 on . Heron Therapeutics, Inc. stock price today i.e. is closed at $1.43,which is 46.64% down from its 52 week high and 43.01% up from its 52 week low.
Heron Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Heron Therapeutics, Inc. (HRTX) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Heron Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Heron Therapeutics, Inc. share’s latest price of $1.43 as on January 21, 2026 at 2:29 am IST, you will get 6.9930 shares of Heron Therapeutics, Inc.. Learn more about
fractional shares .
Heron Therapeutics, Inc. stock has given -91.94% share price returns and 24.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?